Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...
A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.
Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback